Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis. [electronic resource]

By:

Voorneveld, P W

Contributor(s):

Stache, V
Jacobs, R J
Smolders, E
Sitters, A I
Liesker, A
Korkmaz, K S
Lam, S M
De Miranda, N F C C
Morreau, H
Kodach, L L
Hardwick, J C H

Producer: 20131204Description: 1805-12 p. digitalISSN:

1532-1827

Subject(s):

Angiopoietin-1 -- biosynthesis
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- biosynthesis
Biomarkers, Tumor -- genetics
Bone Morphogenetic Protein Receptors, Type I -- genetics
Cell Line, Tumor
Cell Proliferation
Gene Expression Regulation, Neoplastic
Humans
Neoplasm Invasiveness
Neovascularization, Pathologic -- metabolism
Pancreatic Neoplasms -- metabolism
Prognosis
Pyrazoles -- pharmacology
Pyrimidines -- pharmacology
RNA Interference
RNA, Small Interfering
Signal Transduction
Smad4 Protein -- genetics
Survival
Transforming Growth Factor beta -- metabolism
Vascular Endothelial Growth Factor A -- biosynthesis

Online resources:

Available from publisher's website

In: British journal of cancer vol. 109

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Browse results Close

Back to results

1 Review of some pharmacokinetic and pharmacodynamic properties of anti-infective medicines administered to the koala (Phascolarctos cinereus).
by Govendir, M
2 Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent.
by Govendir, M
3 In vitro binding of cefovecin to plasma proteins in Australian marsupials and plasma concentrations of cefovecin following single subcutaneous administration to koalas (Phascolarctos cinereus).
by Gharibi, S
4 Veterinarians' preferences for anticonvulsant drugs for treating seizure disorders in dogs and cats.
by Kluger, E K
5 Morphometric study of the beta-cell volume of the canine pancreas with consideration of the axis of tissue transection.
by Govendir, M
6 In vitro activity of chloramphenicol, florfenicol and enrofloxacin against Chlamydia pecorum isolated from koalas (Phascolarctos cinereus).
by Black, L A
7 Snoring and halitosis in a dog.
by Laurendet, H
8 Pharmacokinetics of fluconazole following intravenous and oral administration to koalas (Phascolarctos cinereus).
by Black, L A
9 Diabetes mellitus in a koala (Phascolarctos cinereus).
by Hemsley, S
10 Inguinal panniculitis in a young Tasmanian devil (Sarcophilus harrisii) caused by Mycobacterium mageritense.
by Reppas, G
11 Evaluation of four warming procedures to minimise heat loss induced by anaesthesia and surgery in dogs.
by Tan, C
12 In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin-clavulanic acid.
by Bennett, A B
13 The use of sevoflurane in a 2:1 mixture of nitrous oxide and oxygen for rapid mask induction of anaesthesia in the cat.
by Tzannes, S
14 Effect of acute haemorrhage on QRS amplitude of the lead II canine electrocardiogram.
by Della Torre, P K
15 In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.
by Bennie, C J M
16 Assessment of florfenicol as a possible treatment for chlamydiosis in koalas (Phascolarctos cinereus).
by Budd, C
17 Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.
by Gharibi, S
18 Absorption of enrofloxacin and marbofloxacin after oral and subcutaneous administration in diseased koalas (Phascolarctos cinereus).
by Griffith, J E
19 Evaluation of enrofloxacin use in koalas (Phascolarctos cinereus) via population pharmacokinetics and Monte Carlo simulation.
by Black, L A
20 Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
by Gottlieb, S

Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis.

APA

Voorneveld P. W., Stache V., Jacobs R. J., Smolders E., Sitters A. I., Liesker A., Korkmaz K. S., Lam S. M., De Miranda N. F. C. C., Morreau H., Kodach L. L. & Hardwick J. C. H. (20131204). Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis. : British journal of cancer.

Chicago

Voorneveld P W, Stache V, Jacobs R J, Smolders E, Sitters A I, Liesker A, Korkmaz K S, Lam S M, De Miranda N F C C, Morreau H, Kodach L L and Hardwick J C H. 20131204. Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis. : British journal of cancer.

Harvard

Voorneveld P. W., Stache V., Jacobs R. J., Smolders E., Sitters A. I., Liesker A., Korkmaz K. S., Lam S. M., De Miranda N. F. C. C., Morreau H., Kodach L. L. and Hardwick J. C. H. (20131204). Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis. : British journal of cancer.

MLA

Voorneveld P W, Stache V, Jacobs R J, Smolders E, Sitters A I, Liesker A, Korkmaz K S, Lam S M, De Miranda N F C C, Morreau H, Kodach L L and Hardwick J C H. Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis. : British journal of cancer. 20131204.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC